1Hadden DR,Patterson Cc,Atkinson A,et al. Macrovasulor disease and hyperglycaemia:10-year survival analysis in Type 2 diabetes mellitus: The Belfast Diet Study[J]. Diabet Med,1997;14(8):663
2Lehto S,Ronnemaa T,Haffner SM. Dyslipidemia and hyperglycemia predict coronnary heart disease events in middle_aged patients with NIDDM[J]. Diabetes,1997;46(8):1354
8Swidan SZ,Montgomery PA.Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus[J]. Pharmacotherapy,1998;18(5):961
9Lehto S, Ronnemaa T, Pyorala K, et al. The mechanism and function of hyperglycemia in patients with myocardial infarction[J]. Arteriosceler Thromb Vasc Biol, 1999;19(4):1014
3Capas SE,Hunt D,Malmberg K,et al.Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without:a systematic overview,Lamcet,2000,355 (9206):773-778.
4Carlson GL. Insulin resistance in sepsis[J]. Br J Surg,2003,90(3):259-260.
5Thorell A, Nygren J, Hirshman MF, et al. Surgery-induced insulin resistance in human patients: relation to glucose transport and utilization[J]. Am J Physiol, 1999,276(4): 754-761.
6Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients[J]. Mayo Clin Proc. 2003,78: 1471-1478.
7Van den Berghe G,Wouters P,Weekers F,et al. Insulin Therapy in Critically ill Patients[J]. N Engl J Med, 2001,345(19):1395-1367.
8Norhammar AM, Ryden L, Malmberg K. Admission plasma glucose: independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients[J]. Diatetes Care, 1999,33: 1827-1831.
9Quinn L. Pharmacologic treatment of the critically ill patient with diabetes[J]. Cirt Care Murs Clin North Am,2002,14(1):81-98.
